Stock Forecast Chart
Stock Price Prediction Summary
Forecast Score Based on 2 Weeks
Based on our forecast, the price of RLAY will decline by -9.07% over the next 2 Weeks and hit $11.40 by Thursday, April 16, 2026. In that time frame, RLAY's share price is expected to range between $10.94 and $11.90.
BearishAverageBullish| Date | Predicted Lower | Predicted | Predicted Upper |
|---|---|---|---|
| Apr 16, 2026 | 11.83 | 12.29 | 12.73 |
| Apr 15, 2026 | 12.08 | 12.55 | 12.97 |
| Apr 14, 2026 | 12.02 | 12.46 | 12.88 |
| Apr 13, 2026 | 11.84 | 12.28 | 12.68 |
| Apr 10, 2026 | 12.02 | 12.46 | 12.91 |
| Apr 9, 2026 | 11.98 | 12.41 | 12.82 |
| Apr 8, 2026 | 12.25 | 12.68 | 13.13 |
| Apr 7, 2026 | 12.17 | 12.59 | 13.03 |
| Apr 6, 2026 | 12.02 | 12.40 | 12.80 |
| Apr 3, 2026 | 12.16 | 12.59 | 13.01 |
RLAY shares rose +16.43% in Thursday, April 2, 2026's trading session, rising from a previous close of $10.77 to move at $12.54. The stock demonstrated notable intraday movement (see RLAY's key stats for a full breakdown), fluctuating between $10.49 and $13.04, a +24.37% trading range. While recent weeks have seen some volatility, RLAY has managed to secure a +25.40% gain over the past 2 weeks. The upward price movement was accompanied by increased trading volume, with approximately 8.89M shares changing hands, 6.49M more than the previous session. This amounted to $111.44M in total market activity.
Will RLAY Continue Its Upward Trend?
According to analyst ratings and projections for RLAY, Relay Therapeutics, Inc. shares are anticipated to increase by +1.49%, potentially reaching $12.73 per share by April 16, 2026. Short-term technical indicators currently suggest a neutral sentiment for RLAY. For deeper insights, view our sentiment analysis on AAPL covering social and institutional perspectives. However, the stock has recorded 16 positive trading days within the past 30 sessions. Based on the RLAY stock forecast, now is a good time to buy RLAY stock because its current trading price is +2.05% above our predicted value, hinting at a possible undervaluation. For deeper insights, view our sentiment analysis on RLAY covering social and institutional perspectives.
RLAY Technical Momentum: Overbought, Oversold, or Neutral?
An analysis of Relative Strength Index (RSI) indicators provides insight into RLAY's momentum. Short-term RSIs (9, 14, and 20-day figures ranging from 69.12% to 77.52%) indicate the stock is leaning toward a strong bullish momentum phase. The 50-day RSI, at 63.53%, suggests strong medium-term momentum. Additionally, the 100-day RSI, at 60.61%, points to growing bullish momentum over the long term. Insights into RLAY's shareholder base show how institutional investors are positioning themselves during these momentum shifts
Relay Therapeutics Short-Term Forecasts
RLAY Forecast For Next 5 Days
Our algorithm anticipates Relay Therapeutics (RLAY) stock could hit $13.16 by Apr 10, 2026. This represents a +4.97% fall from today's price, following a -5.00% change over the past five days.
RLAY Forecast For Next 30 Days
Based on analysis of market trends, the outlook for Relay Therapeutics, Inc. (RLAY) stock over the next 30 days is largely positive. Price forecasts suggest an average target of $12.66, which would mean a +0.96% increase from the current price of $12.54. Projections for this period range from a high of $13.71 to a low of $11.70.
RLAY Forecast For Next 90 Days
Our proprietary market analysis suggests predictions for Relay Therapeutics's price over the next three months point to a rise. RLAY stock is expected to peak at $31.81 on Jul 03, 2026 after potentially dipping to $18.80 on Apr 24, 2026. On average, RLAY is likely to trade around $25.60 in the coming 90 days.
Relay Therapeutics Stock Forecast 2025
Based on our predictive models, Relay Therapeutics (RLAY) is expected to trade between $18.80 and $65.76 throughout 2026. This would result in an average price of $39.66, potentially offering investors a +216.27% return from current levels.
Relay Therapeutics, Inc. Monthly Forecast 2026–2027
April 2026
According to our latest forecast models, Relay Therapeutics, Inc. (RLAY) is positioned to show a strong performance in April 2026. The price is predicted to move between $18.80 and $23.22, settling at an average of $20.74. This could translate to a +65.39% gain.
May 2026
Based on current market signals, Relay Therapeutics, Inc. is projected to trend may 2026. We forecast a trading range from $19.25 to $28.92, with a likely average price of $25.07. Investors could expect a potential return of +99.92%.
June 2026
Our predictive algorithms indicate Relay Therapeutics, Inc. stock may see a shift in June 2026. The expected range spans $28.43–$31.69, with an average target of $29.55. This represents a positive outlook and a possible gain of +135.65%.
July 2026
Analyzing established trends, Relay Therapeutics, Inc. looks set to move in July 2026. Projections place the stock between $30.52 and $43.63, averaging around $36.93. This suggests a +194.50% gain from current levels.
August 2026
Market indicators suggest Relay Therapeutics, Inc. could experience notable changes during August 2026. Prices could fluctuate within $41.50 to $44.94, with a midpoint forecast of $42.65. The stock might deliver a +240.11% gain.
September 2026
Forecasting for September 2026, models estimate that Relay Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $40.48 and $48.08, averaging $42.67. This signals a positive trajectory with potential returns around +240.27%.
October 2026
According to our latest forecast models, Relay Therapeutics, Inc. (RLAY) is positioned to show a strong performance in October 2026. The price is predicted to move between $45.03 and $57.21, settling at an average of $51.07. This could translate to a +307.26% gain.
November 2026
Based on current market signals, Relay Therapeutics, Inc. is projected to trend november 2026. We forecast a trading range from $48.06 to $55.70, with a likely average price of $50.58. Investors could expect a potential return of +303.35%.
December 2026
Our predictive algorithms indicate Relay Therapeutics, Inc. stock may see a shift in December 2026. The expected range spans $47.33–$65.76, with an average target of $54.49. This represents a positive outlook and a possible gain of +334.53%.
January 2027
Analyzing established trends, Relay Therapeutics, Inc. looks set to move in January 2027. Projections place the stock between $47.07 and $65.18, averaging around $53.96. This suggests a +330.30% gain from current levels.
February 2027
Market indicators suggest Relay Therapeutics, Inc. could experience notable changes during February 2027. Prices could fluctuate within $44.74 to $54.13, with a midpoint forecast of $45.83. The stock might deliver a +265.47% gain.
March 2027
Forecasting for March 2027, models estimate that Relay Therapeutics, Inc. may undergo key fluctuations. If trends hold, the stock might trade between $49.45 and $58.50, averaging $50.00. This signals a positive trajectory with potential returns around +298.72%.
April 2027
According to our latest forecast models, Relay Therapeutics, Inc. (RLAY) is positioned to show a strong performance in April 2027. The price is predicted to move between $49.24 and $54.43, settling at an average of $48.19. This could translate to a +284.29% gain.
RLAY's history of dividends and stock splits also plays a role in long-term investor confidence.

